POTENTIAL IDENTIFIABILITY AND PREVENTABILITY OF ADVERSE EVENTS USING INFORMATION-SYSTEMS

被引:102
作者
BATES, DW [1 ]
ONEIL, AC [1 ]
BOYLE, D [1 ]
TEICH, J [1 ]
CHERTOW, GM [1 ]
KOMAROFF, AL [1 ]
BRENNAN, TA [1 ]
机构
[1] HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115
关键词
D O I
10.1136/jamia.1994.95153428
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Study Objective: To evaluate the potential ability of computerized information systems (ISs) to identify and prevent adverse events in medical patients. Design: Clinical descriptions of all 133 adverse events identified through chart review for a cohort of 3,138 medical patients were evaluated by two reviewers. Measurements: For each adverse event, three hierarchical levels of IS sophistication were considered: Level 1-demographics, results for all diagnostic tests, and current medications would be available on-line; Level 2-all orders would be entered on-line by physicians; and Level 3-additional clinical data, such as automated problem lists, would be available on-line. Potential for event identification and potential for event prevention were scored by each reviewer according to two distinct sets of event monitors. Results: Of all the adverse events, 53% were judged identifiable using Level 1 information, 58% were judged identifiable using Level 2 information, and 89% were judged identifiable using Level 3 information. The highest-yield event monitors for identifying adverse events wee ''panic'' laboratory results, unexpected transfer to an intensive care unit, and hospital-incurred trauma. With information from Levels 1, 2, and 3, 5%, 13%, and 23% of the adverse events, respectively, were judged preventable. For preventing these adverse events, guided-dose algorithms, drug-laboratory checks, and drug-patient characteristic checks held the most potential.
引用
收藏
页码:404 / 411
页数:8
相关论文
共 38 条
[1]  
BATES DW, 1992, CLIN RES, V40, pA347
[2]  
BATES DW, 1993, CLIN RES, V41, pA543
[3]   SENSITIVITY AND SPECIFICITY OF 3 METHODS OF DETECTING ADVERSE DRUG-REACTIONS [J].
BERRY, LL ;
SEGAL, R ;
SHERRIN, TP ;
FUDGE, KA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (07) :1534-1539
[4]   TOWARD AN APPLIED TECHNOLOGY FOR QUALITY MEASUREMENT IN HEALTH-CARE [J].
BERWICK, DM .
MEDICAL DECISION MAKING, 1988, 8 (04) :253-258
[5]   DEVELOPMENT OF A COMPUTERIZED LABORATORY ALERTING SYSTEM [J].
BRADSHAW, KE ;
GARDNER, RM ;
PRYOR, TA .
COMPUTERS AND BIOMEDICAL RESEARCH, 1989, 22 (06) :575-587
[6]   INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I [J].
BRENNAN, TA ;
LEAPE, LL ;
LAIRD, NM ;
HEBERT, L ;
LOCALIO, AR ;
LAWTHERS, AG ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :370-376
[7]   BIAS, PREVALENCE AND KAPPA [J].
BYRT, T ;
BISHOP, J ;
CARLIN, JB .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (05) :423-429
[8]  
Classen, 1992, HOSP PHARM, V27, P776
[9]  
Classen D C, 1992, Hosp Pharm, V27, P776
[10]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851